Vera Therapeutics, Inc. (VERA)
34.26
-0.08
(-0.23%)
USD |
NASDAQ |
May 27, 16:00
34.26
0.00 (0.00%)
After-Hours: 16:39
Vera Therapeutics Cash from Investing (Quarterly) : -137.82M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -36.46M |
| Syndax Pharmaceuticals, Inc. | 38.39M |
| United Therapeutics Corp. | 743.70M |
| Biogen, Inc. | -209.50M |
| Cytokinetics, Inc. | 145.49M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -106.50M |
| Cash from Financing (Quarterly) | 3.942M |
| Free Cash Flow | -293.81M |
| Free Cash Flow Per Share (Quarterly) | -1.492 |
| Free Cash Flow to Equity (Quarterly) | -104.40M |
| Free Cash Flow to Firm (Quarterly) | -104.85M |
| Free Cash Flow Yield | -12.97% |